02 the us biosimilars regulatory pathway
Published 7 years ago • 1K plays • Length 19:39Download video MP4
Download video MP3
Similar videos
-
14:19
regulatory pathway for biosimilars
-
4:12
the basics of biosimilars
-
2:47
biosimilars: approval process
-
4:05
the biosimilar regulatory pathway
-
1:36
interchangeable biosimilars
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
5:20
data requirements for biosimilars
-
1:44
fast facts about the regulatory approval pathway for biosimilars – amgen science
-
3:33
biosimilars: manufacturing and inherent variation
-
15:01
euronews debates highlights | how can europe shape the future of biosimilar medicines?
-
14:14
bio-processing overview (upstream and downstream process)
-
4:20
the biosimilar development process
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
2:03
biosimilars interchangeability
-
3:02
biosimilar medications — what patients need to know
-
2:04
biosimilars: the path to approval
-
32:37
biologics, biosimilars, and the two-fold u.s. approval framework’s possible impact on prices
-
3:07
the promise of biosimilars
-
1:58
fda review and approval process for biosimilar medications
-
38:15
biosimilars and biologics
-
13:25
biosimilars part 2: regulatory and current status